Company
Technology
Programs
Partnering
News
Contact
- Where to meet us
- Disclaimer

GRC_logo

Home » okklo contributes to Gordon Research Conference on orphan diseases » GRC_logo

02/12/2013 Daniel Zollinger

Recente berichten

Okklo’s hematology asset will be further developed by Alveron Pharma05/16/2019
Okklo and SolAeroMed partner to develop cyclodextrins for cystic fibrosis treatment06/27/2017
Okklo Life Sciences B.V. and Sanquin sign commercialization agreement to enter IND enabling studies and clinical development.01/10/2017

Populaire berichten

Okklo’s hematology asset will be further developed by Alveron Pharma05/16/2019
B4B meeting Frankfurt – okklo in rare diseases consortium07/02/2012
okklo receives IPC grant07/02/2012

Company
Technology
Programs
Partnering
News
Contact

Copyright © 2016 | Okklo Life Sciences | All Rights Reserved